Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × Postoperative Period × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stomach Neoplasms 1 Solid Tumor Spine Metastases 1 Sarcoma 1 Rectal Neoplasms 1 Oligodendroglioma 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Lymphoma, Follicular 1 Head and Neck Neoplasms 1 Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Astrocytoma 1 Anxiety Disorders 1 Amenorrhea 1

Interventions

Doxorubicin 122 Ifosfamide 70 Radiotherapy 65 Cyclophosphamide 62 Gemcitabine 54 Filgrastim 46 Trabectedin 36 pazopanib 35 Docetaxel 35 pembrolizumab 33 Etoposide 33 Vincristine 31 Cisplatin 29 Nivolumab 27 Irinotecan 21 Magnetic Resonance Spectroscopy 20 Carboplatin 20 Ipilimumab 19 Surgical Procedures, Operative 18 Radiation 18 Temozolomide 17 Bevacizumab 17 Mesna 16 Melphalan 16 Biopsy 16 eribulin 15 Sirolimus 15 Granulocyte Colony-Stimulating Factor 15 Drug Therapy 15 Dactinomycin 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03896620 2025-12-24

Recognition of Circulating Tumor DNA in Soft Tissue Sarcoma

Medical College of Wisconsin

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡